当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 资产负债表

尔康制药

(300267)

  

流通市值:45.66亿  总市值:66.21亿
流通股本:14.22亿   总股本:20.63亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金686,061,848.21698,537,949.74668,368,156.84638,895,895.28
应收票据及应收账款168,086,915.87151,266,539.49131,476,574.59132,007,528.12
其中:应收票据27,231,063.6548,084,670.2140,464,805.5724,571,252.48
应收账款140,855,852.22103,181,869.2891,011,769.02107,436,275.64
应收款项融资50,276,469.347,037,042.7426,909,443.3440,518,259.15
预付款项6,918,682.4822,581,009.4813,128,590.39,167,340.1
其他应收款合计5,577,491.914,463,359.9725,487,884.7410,886,556.67
存货670,915,258.88600,778,587.41648,344,562.54691,485,904.88
其他流动资产68,878,749.972,417,167.5365,334,745.0969,286,444.91
流动资产平衡项目0000
流动资产合计1,676,715,416.551,717,081,656.361,679,049,957.441,692,247,929.11
非流动资产:
长期股权投资71,733,391.1871,740,298.04119,527,524.25119,657,377.27
其他权益工具投资50,000,00050,000,00050,000,00050,000,000
投资性房地产77,281,203.9478,082,573.7778,883,943.5679,685,313.39
固定资产2,358,642,775.692,384,972,862.952,518,734,356.882,552,118,924.01
在建工程180,278,281.81174,575,234.39236,790,125.51245,915,335.69
使用权资产152,001,178.79156,810,231.01136,505,911.58117,029,224.76
无形资产359,177,359.72363,556,194.17361,014,016.27366,611,169.51
商誉2,003,166.562,003,166.562,003,166.562,003,166.56
长期待摊费用10,347,062.1410,664,002.910,900,394.2410,960,140.11
递延所得税资产148,937,537.3150,546,083.18151,790,359.25151,729,801.01
其他非流动资产37,212,303.2339,702,187.8648,893,224.3240,055,253.27
非流动资产平衡项目0000
非流动资产合计3,447,614,260.363,482,652,834.833,715,043,022.423,735,765,705.58
资产平衡项目0000
资产总计5,124,329,676.915,199,734,491.195,394,092,979.865,428,013,634.69
流动负债:
短期借款401,261,527.78488,198,472.23399,393,472.23340,208,472.23
交易性金融负债--822,000-
应付票据及应付账款121,501,523.94114,656,240.33122,547,840.63146,139,329.3
应付账款121,501,523.94114,656,240.33122,547,840.63146,139,329.3
合同负债44,888,164.2229,823,202.441,502,079.5238,952,466.02
应付职工薪酬9,288,902.9520,222,658.149,363,5399,937,343.88
应交税费2,379,211.66,675,631.417,246,251.918,027,117.55
其他应付款合计26,497,619.2628,565,572.2626,546,086.9526,793,656.84
一年内到期的非流动负债3,693,788.513,693,966.4920,021.891,872,660.57
其他流动负债9,309,400.6713,506,321.0918,600,848.613,900,297.02
流动负债平衡项目0000
流动负债合计618,820,138.93705,342,064.26626,942,140.73585,831,343.41
非流动负债:
租赁负债17,087,226.5317,375,180.585,962,052.91385,365.17
预计负债12,993,511.8812,993,511.88--
递延收益13,690,331.9714,929,804.0516,169,276.1317,408,748.21
递延所得税负债46,979,360.1346,900,119.9346,670,219.8946,568,652.78
非流动负债平衡项目0000
非流动负债合计90,750,430.5192,198,616.4468,801,548.9364,362,766.16
负债平衡项目0000
负债合计709,570,569.44797,540,680.7695,743,689.66650,194,109.57
所有者权益(或股东权益):
实收资本(或股本)2,062,604,8702,062,604,8702,062,604,8702,062,604,870
资本公积1,019,459,930.441,019,459,930.441,019,459,930.441,019,459,930.44
其他综合收益49,104,126.3160,572,012.39-8,886,059.6837,291,480.39
专项储备871,530.76697,655.76664,399.18659,970.26
盈余公积138,000,248.18138,000,248.18129,884,442.27129,884,442.27
未分配利润1,194,203,400.811,166,090,815.591,522,110,741.091,553,878,212.6
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,464,244,106.54,447,425,532.364,725,838,323.34,803,778,905.96
少数股东权益-49,484,999.03-45,231,721.87-27,489,033.1-25,959,380.84
股东权益平衡项目0000
股东权益合计4,414,759,107.474,402,193,810.494,698,349,290.24,777,819,525.12
负债和股东权益合计5,124,329,676.915,199,734,491.195,394,092,979.865,428,013,634.69
公告日期2025-04-232025-04-232024-10-252024-08-29
审计意见(境内)标准无保留意见
TOP↑